Recalls / Active ingredient / Dapagliflozin Propanediol
Dapagliflozin Propanediol
2 FDA drug recalls involving the active ingredient “Dapagliflozin Propanediol”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-15 | Class II | xigduo XR (dapagliflozin/metformin HCl extended-release) tablets 5 mg/1000 mg 60 Tablets Rx only NDC 0310-6260 | Cardinal Health Inc. |
| 2021-03-15 | Class II | xigduo XR (dapgliflozin/metformin HCl extended-release) tablets 10 mg/1000 mg 30 Tablets Rx only NDC 0310-6280 | Cardinal Health Inc. |